Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 September 2023 | Story Samkelo Fetile

The University of the Free State (UFS) is set to host a compelling book launch event, exploring the lasting legacy of apartheid. This thought-provoking gathering is organised by the Deputy Vice-Chancellors (Research and Internationalisation; Institutional Change, Strategic Partnerships and Societal Impact), the Directorate for Institutional Advancement, and the Faculties of Law (Centre for Human Rights) and The Humanities, with a cocktail reception to follow.

The overarching question guiding the event is a thought-provoking one: Even though apartheid has formally ended, to what extent does its legacy persist? This enquiry sets the stage for an exploration of diverse facets of this legacy by three distinguished authors – Premesh Lalu, Wahbie Long, and Saleem Badat. Their recently published works, namely Undoing Apartheid (Polity Press, 2022), Nation on the Couch: Inside South Africa’s Mind (MF Books, 2021), and Tennis, Apartheid and Social Justice: The First Non-Racial International Tennis Tour, 1971 (UKZN Press, 2023), respectively offer textured insights into the enduring shadows cast by apartheid on contemporary realities.

These authors will engage in a conversation with Sarah Nuttall, Professor of Literary and Cultural Studies at Wits and the former Director of the Wits Institute for Social and Economic Research (WISER), who served in that capacity from 2012 to 2022.


Date: 12 October 2023

Time: 16:30-18:30

Venue: Albert Wessels Auditorium, UFS Bloemfontein Campus

For those interested in attending, RSVP by 6 October 2023 through the event registration. For further information, contact Alicia Pienaar at pienaaran1@ufs.ac.za.

The Speakers

The speakers include Premesh Lalu, Research Professor and former founding director of the Centre for Humanities Research (CHR) at the University of the Western Cape (UWC); Wahbie Long, Professor in the Department of Psychology and Deputy Dean in the Faculty of Humanities at the University of Cape Town (UCT); and Saleem Badat, Research Professor in the Department of History at the UFS, former Programme Director of International Higher Education and Strategic Projects at the Andrew Mellon Foundation in New York, and former Vice-Chancellor of Rhodes University.

As South Africa grapples with the lingering impact of its apartheid history, this event promises an insightful exploration of the continuing reverberations of this historical trauma, inviting participants to reflect on the ways in which it continues to shape the present.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept